Healthcare Pharmaceutical Biotech

Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and Individualized Clinical Care

September 3, 2026 5:07 PM

Medical tourism provider Istanbul Care today announced its 2026 operational protocol for international hair restoration patients. Designed to replace opaque per-graft pricing models, the clinic's updated offering integrates all-inclusive flat-rate pricing with standardized, doctor-led clinical assessment and long-term post-operative monitoring. Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and...

Read more

Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results

September 3, 2026 4:00 PM

PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026. Quarter Ended June 30, 2026 Net sales for the three months ended June 30, 2026 increased $2.9 million, or 17%, to $20.4 million from $17.5 million for the three months ended June 30, 2025, due primarily to increased revenue from our largest customer's next generation orthopedic handpiece. Gross profit for the...

Read more

Odyssey Behavioral Healthcare Marks 10 Years with Measurable Clinical Outcomes Across Mental Health, Substance Use and Eating Disorder Programs

September 3, 2026 1:00 PM

Odyssey Behavioral Healthcare today released its 2025 clinical outcomes, marking 10 years of measurable, data-driven care across its specialized mental health, substance use and eating disorder programs since the organization's founding in 2015. Across Odyssey's residential eating disorder programs, clients experienced an average 59% reduction in eating disorder symptom severity over the measured period. Across its mental health and substance...

Read more

BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress

September 3, 2026 11:15 AM

BioAdaptives, Inc. (OTCID:BDPT), a developer of science-driven human renewal formulations, today announced that the first commercial orders for XcellaraHeart™ will ship next week. The milestone marks the formal transition of the Company's flagship Xcellara™ cellular wellness platform from research and development to commercial execution. In addition to initial product shipments, BioAdaptives outlined key operational, commercial, and balance...

Read more

Action Behavior Centers' Family Advocacy Team Meets with State Lawmakers in Texas to Discuss Access to ABA Therapy for Autism

September 3, 2026 10:45 AM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), is taking an active role in state and federal advocacy efforts to protect and expand access to autism services across Texas. Texas Legislative Staff Tours ABC's Mueller Center This summer, ABC welcomed staff from the Texas Legislature to its Mueller ABA Center in Austin, Texas,...

Read more

DistillerSR Joins European MedTech Consortium to Digitalize Medical Device and IVD Conformity Assessments

September 3, 2026 10:00 AM

DistillerSR, the market leader in AI-enabled literature review automation and evidence management, today announced its participation in DIGICAP (DIGItalisation of the Conformity Assessment Process), a €4 million European initiative uniting 19 organizations across 12 EU countries to digitalize how medical devices and in vitro diagnostics are certified for the European market. The project is funded under Horizon Europe, the world's largest...

Read more

The Next Healthcare IT Revenue Stream Is Credit, Black Book Research Finds

September 3, 2026 9:10 AM

Healthcare software companies are beginning to compete on more than technology. A new Black Book Research study finds that access to capital, and the ability to embed financing into provider, patient and reimbursement workflows, is emerging as a critical source of product differentiation, transaction revenue and enterprise value. The vendor-agnostic industry report, "Embedded Capital in Healthcare IT: The Product Stack and Capital Stack Are...

Read more

Rural Pharmacies Identify Thousands of Patients at Risk of Stroke, Heart Disease, Pilot Program Finds

September 3, 2026 9:00 AM

Originally published on NCPA.org A trailblazing new program using rural pharmacies to identify and screen patients at risk of stroke and heart disease may have saved hundreds of lives, improved outcomes for thousands of patients, and saved millions of dollars by preventing hospitalization. The pilot program is a collaboration between the National Community Pharmacists Association's (NCPA) Innovation Center, CPESN® Community Health, and Bristol...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Prepares First Custom StrainScan Pro Demos for Enterprise Agricultural Clients

September 3, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that it is preparing the first custom demonstrations of its StrainScan Pro platform for enterprise agricultural clients - a key step in converting the Company's AI vision technology from public positioning into direct enterprise engagement. StrainScan Pro is proprietary AI vision software built for agricultural and foodservice quality applications. The platform is designed to support...

Read more

Back-to-School Health Checklist: What Parents Can Do To Help Kids Start the School Year Strong

September 3, 2026 8:30 AM

As summer winds down, many families are preparing for a new school year filled with new teachers, new routines and new opportunities. But before students head back to the classroom, it is important to make sure their health needs are covered. From school physicals and vaccinations to managing chronic conditions and preventing common illnesses, MinuteClinic providers say early planning can make a big difference. "Back-to-school season can feel...

Read more

Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML

September 3, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced a 93% clinical benefit rate with its mipletamig triplet in evaluable frontline acute myeloid leukemia (AML) patients with TP53 mutations, one of the most difficult-to-treat forms of the disease and a patient population that has historically responded poorly to treatment. "TP53-mutated AML...

Read more

Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements

September 3, 2026 8:00 AM

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the system's functionality and providing users with greater flexibility and...

Read more

IRLAB's CEO Intends to Step Down During the First Quarter of 2027

September 3, 2026 5:10 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announces today that Kristina Torfgård has informed the Board of Directors that she wishes to step down from her position as CEO. She will remain in the CEO role until the first quarter of 2027, creating good conditions for a smooth transition to her successor. The Board of Directors will immediately initiate the work to...

Read more

Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

September 3, 2026 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has received notices to exercise warrants over 96,825 new ordinary shares in the Company (the "Warrant Shares"). The Company has received notices to exercise warrants over 96,825 new Ordinary Shares at exercise prices ranging from 180p to 350p, raising £291,665 for the Company. Admission and Total Voting Rights Application will be made for the Warrant Shares, which will rank pari passu...

Read more

SynAct Pharma's CEO and CSO Sell Shares

September 3, 2026 1:50 AM

SynAct Pharma AB (STO:SYNACT) ("SynAct Pharma" or the "Company") today announces that the Company's Chief Executive Officer, Jeppe Øvlesen, and the Company's CSO, Thomas Jonassen, have sold shares in the Company to enable payment of capital gain tax. Jeppe Øvlesen's sale of a total of 150,000 shares at a price of SEK 17.8 per share was carried out through the closely associated company Quantass Aps. Following the sale, Jeppe Øvlesen holds...

Read more

The Grand Self Documentary Invites Audiences to Explore Human Potential, Self-Discovery, and the Illusion of Separation

September 2, 2026 3:10 PM

The Grand Self: Dissolving the Illusion of Separation is inviting audiences around the world to experience a feature-length documentary centered on one fundamental question: Who are we beneath the beliefs, conditioning, and identities we have accumulated throughout our lives? The film follows a personal journey of self-discovery while incorporating perspectives from a diverse international collection of experts and featured speakers. Through...

Read more

Action Behavior Centers' Family Advocacy Team Meets with U.S. Senators in North Carolina to Discuss Access to ABA Therapy for Autism

September 2, 2026 2:55 PM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), is taking an active role in state and federal advocacy efforts to protect and expand access to autism services nationwide. In August, ABC's Family Advocacy team welcomed legislative staff to its center in Clayton, North Carolina, working alongside policymakers to support equitable...

Read more

Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"

September 2, 2026 1:55 PM

A filing entered on August 24, 2026 in the United States District Court for the Northern District of Illinois has placed the marketing of state-licensed recreational cannabis at the center of a contested discovery dispute, at the same moment the federal government has extended Schedule III treatment and its accompanying economic benefits to state-licensed operators. The filing is Plaintiffs' Memorandum of Law in Opposition to Defendants'...

Read more

SunTech Medical Launches Dedicated Veterinary Website, SunTechVet.com

September 2, 2026 12:05 PM

Patient monitoring has become an essential component of modern veterinary medicine, supporting clinical decisions from the exam room to the operating suite. To increase awareness of veterinary monitoring technologies and provide easier access to product information, educational resources, and purchasing options, SunTech Medical has launched SunTechVet.com, a dedicated website for veterinary professionals. Designed as a comprehensive resource,...

Read more

Maria Regina Rehabilitation and Nursing Earns CMS Overall Five-Star Quality Rating

September 2, 2026 12:00 PM

Maria Regina Rehabilitation and Nursing has earned the Overall Five-Star Quality Rating from the Centers for Medicare & Medicaid Services (CMS), the highest overall rating awarded through CMS's Five-Star Quality Rating System. The achievement recognizes the facility's strong performance and continued commitment to delivering high-quality skilled nursing, rehabilitation, and long-term care services in a compassionate, resident-centered...

Read more